These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 17127096)

  • 21. CHIP and Hsp70 regulate tau ubiquitination, degradation and aggregation.
    Petrucelli L; Dickson D; Kehoe K; Taylor J; Snyder H; Grover A; De Lucia M; McGowan E; Lewis J; Prihar G; Kim J; Dillmann WH; Browne SE; Hall A; Voellmy R; Tsuboi Y; Dawson TM; Wolozin B; Hardy J; Hutton M
    Hum Mol Genet; 2004 Apr; 13(7):703-14. PubMed ID: 14962978
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stress and molecular chaperones in disease.
    Macario AJ; Conway de Macario E
    Int J Clin Lab Res; 2000; 30(2):49-66. PubMed ID: 11043498
    [TBL] [Abstract][Full Text] [Related]  

  • 23. U-box protein carboxyl terminus of Hsc70-interacting protein (CHIP) mediates poly-ubiquitylation preferentially on four-repeat Tau and is involved in neurodegeneration of tauopathy.
    Hatakeyama S; Matsumoto M; Kamura T; Murayama M; Chui DH; Planel E; Takahashi R; Nakayama KI; Takashima A
    J Neurochem; 2004 Oct; 91(2):299-307. PubMed ID: 15447663
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Involvement of the ubiquitin-proteasome pathway and molecular chaperones in oculopharyngeal muscular dystrophy.
    Abu-Baker A; Messaed C; Laganiere J; Gaspar C; Brais B; Rouleau GA
    Hum Mol Genet; 2003 Oct; 12(20):2609-23. PubMed ID: 12944420
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HSJ1 is a neuronal shuttling factor for the sorting of chaperone clients to the proteasome.
    Westhoff B; Chapple JP; van der Spuy J; Höhfeld J; Cheetham ME
    Curr Biol; 2005 Jun; 15(11):1058-64. PubMed ID: 15936278
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of molecular chaperones in human misfolding diseases.
    Broadley SA; Hartl FU
    FEBS Lett; 2009 Aug; 583(16):2647-53. PubMed ID: 19393652
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Flexible nets of malleable guardians: intrinsically disordered chaperones in neurodegenerative diseases.
    Uversky VN
    Chem Rev; 2011 Feb; 111(2):1134-66. PubMed ID: 21086986
    [No Abstract]   [Full Text] [Related]  

  • 28. Unraveling the CHIP:Hsp70 complex as an information processor for protein quality control.
    VanPelt J; Page RC
    Biochim Biophys Acta Proteins Proteom; 2017 Feb; 1865(2):133-141. PubMed ID: 27863257
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CHIP-ping away at tau.
    Goryunov D; Liem RK
    J Clin Invest; 2007 Mar; 117(3):590-2. PubMed ID: 17332887
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia.
    Calabrese V; Lodi R; Tonon C; D'Agata V; Sapienza M; Scapagnini G; Mangiameli A; Pennisi G; Stella AM; Butterfield DA
    J Neurol Sci; 2005 Jun; 233(1-2):145-62. PubMed ID: 15896810
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Carboxyl terminus of hsc70-interacting protein (CHIP) can remodel mature aryl hydrocarbon receptor (AhR) complexes and mediate ubiquitination of both the AhR and the 90 kDa heat-shock protein (hsp90) in vitro.
    Morales JL; Perdew GH
    Biochemistry; 2007 Jan; 46(2):610-21. PubMed ID: 17209571
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A CHIPotle in physiology and disease.
    Paul I; Ghosh MK
    Int J Biochem Cell Biol; 2015 Jan; 58():37-52. PubMed ID: 25448416
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vivo evidence of CHIP up-regulation attenuating tau aggregation.
    Sahara N; Murayama M; Mizoroki T; Urushitani M; Imai Y; Takahashi R; Murata S; Tanaka K; Takashima A
    J Neurochem; 2005 Sep; 94(5):1254-63. PubMed ID: 16111477
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MKKS is a centrosome-shuttling protein degraded by disease-causing mutations via CHIP-mediated ubiquitination.
    Hirayama S; Yamazaki Y; Kitamura A; Oda Y; Morito D; Okawa K; Kimura H; Cyr DM; Kubota H; Nagata K
    Mol Biol Cell; 2008 Mar; 19(3):899-911. PubMed ID: 18094050
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Cytosolic protein quality control system--the role of molecular chaperones in the biology of neurodegenerative diseases].
    Guenther I; Kedzierska-Mieszkowska S
    Postepy Biochem; 2011; 57(3):274-82. PubMed ID: 22235653
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CHIP: A new modulator of human malignant disorders.
    Cao Z; Li G; Shao Q; Yang G; Zheng L; Zhang T; Zhao Y
    Oncotarget; 2016 May; 7(20):29864-74. PubMed ID: 27007160
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neurodegeneration and the Heat Shock Protein 70 Machinery: Implications for Therapeutic Development.
    Fontaine SN; Martin MD; Dickey CA
    Curr Top Med Chem; 2016; 16(25):2741-52. PubMed ID: 27072702
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lanosterol Suppresses the Aggregation and Cytotoxicity of Misfolded Proteins Linked with Neurodegenerative Diseases.
    Upadhyay A; Amanullah A; Mishra R; Kumar A; Mishra A
    Mol Neurobiol; 2018 Feb; 55(2):1169-1182. PubMed ID: 28102469
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evolving connections between molecular chaperones and neuronal function.
    Calderwood SK
    Int J Hyperthermia; 2005 Aug; 21(5):375-8. PubMed ID: 16048835
    [No Abstract]   [Full Text] [Related]  

  • 40. BAG2 structure, function and involvement in disease.
    Qin L; Guo J; Zheng Q; Zhang H
    Cell Mol Biol Lett; 2016; 21():18. PubMed ID: 28536620
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.